nodes	percent_of_prediction	percent_of_DWPC	metapath
Ziprasidone—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0715	0.192	CbGbCtD
Ziprasidone—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0475	0.128	CbGbCtD
Ziprasidone—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0475	0.128	CbGbCtD
Ziprasidone—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0368	0.0987	CbGbCtD
Ziprasidone—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0357	0.0958	CbGbCtD
Ziprasidone—HTR1B—dura mater—ankylosing spondylitis	0.0303	0.434	CbGeAlD
Ziprasidone—HTR1D—dura mater—ankylosing spondylitis	0.0293	0.421	CbGeAlD
Ziprasidone—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0279	0.0748	CbGbCtD
Ziprasidone—CYP3A4—Betamethasone—ankylosing spondylitis	0.0239	0.0642	CbGbCtD
Ziprasidone—CYP3A4—Prednisolone—ankylosing spondylitis	0.0236	0.0634	CbGbCtD
Ziprasidone—CYP3A4—Prednisone—ankylosing spondylitis	0.0223	0.0598	CbGbCtD
Ziprasidone—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0219	0.0587	CbGbCtD
Ziprasidone—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0139	0.0373	CbGbCtD
Ziprasidone—HTR2A—vertebral column—ankylosing spondylitis	0.00437	0.0628	CbGeAlD
Ziprasidone—H1F0—tendon—ankylosing spondylitis	0.00164	0.0236	CbGeAlD
Ziprasidone—HTR7—tendon—ankylosing spondylitis	0.00101	0.0146	CbGeAlD
Ziprasidone—ADRA2C—tendon—ankylosing spondylitis	0.000932	0.0134	CbGeAlD
Ziprasidone—HRH1—tendon—ankylosing spondylitis	0.000757	0.0109	CbGeAlD
Ziprasidone—ADRA2A—tendon—ankylosing spondylitis	0.000744	0.0107	CbGeAlD
Ziprasidone—HTR2A—tendon—ankylosing spondylitis	0.000633	0.00908	CbGeAlD
Ziprasidone—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000584	0.00105	CcSEcCtD
Ziprasidone—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000582	0.00104	CcSEcCtD
Ziprasidone—Myalgia—Triamcinolone—ankylosing spondylitis	0.000577	0.00103	CcSEcCtD
Ziprasidone—Pneumonia—Methotrexate—ankylosing spondylitis	0.000576	0.00103	CcSEcCtD
Ziprasidone—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000576	0.00103	CcSEcCtD
Ziprasidone—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000576	0.00103	CcSEcCtD
Ziprasidone—Eye disorder—Prednisone—ankylosing spondylitis	0.000575	0.00103	CcSEcCtD
Ziprasidone—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000574	0.00103	CcSEcCtD
Ziprasidone—Infestation—Methotrexate—ankylosing spondylitis	0.000573	0.00103	CcSEcCtD
Ziprasidone—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000573	0.00103	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000572	0.00103	CcSEcCtD
Ziprasidone—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000565	0.00101	CcSEcCtD
Ziprasidone—Renal failure—Methotrexate—ankylosing spondylitis	0.000563	0.00101	CcSEcCtD
Ziprasidone—Angioedema—Dexamethasone—ankylosing spondylitis	0.000562	0.00101	CcSEcCtD
Ziprasidone—Angioedema—Betamethasone—ankylosing spondylitis	0.000562	0.00101	CcSEcCtD
Ziprasidone—Angiopathy—Prednisone—ankylosing spondylitis	0.000558	0.001	CcSEcCtD
Ziprasidone—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000557	0.000998	CcSEcCtD
Ziprasidone—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000557	0.000998	CcSEcCtD
Ziprasidone—Immune system disorder—Prednisone—ankylosing spondylitis	0.000556	0.000996	CcSEcCtD
Ziprasidone—Vertigo—Betamethasone—ankylosing spondylitis	0.000553	0.000991	CcSEcCtD
Ziprasidone—Vertigo—Dexamethasone—ankylosing spondylitis	0.000553	0.000991	CcSEcCtD
Ziprasidone—Syncope—Betamethasone—ankylosing spondylitis	0.000552	0.000989	CcSEcCtD
Ziprasidone—Syncope—Dexamethasone—ankylosing spondylitis	0.000552	0.000989	CcSEcCtD
Ziprasidone—Arrhythmia—Prednisone—ankylosing spondylitis	0.00055	0.000985	CcSEcCtD
Ziprasidone—Infection—Triamcinolone—ankylosing spondylitis	0.00055	0.000985	CcSEcCtD
Ziprasidone—Sweating—Methotrexate—ankylosing spondylitis	0.000549	0.000984	CcSEcCtD
Ziprasidone—Infection—Methylprednisolone—ankylosing spondylitis	0.000549	0.000983	CcSEcCtD
Ziprasidone—Haematuria—Methotrexate—ankylosing spondylitis	0.000546	0.000979	CcSEcCtD
Ziprasidone—Shock—Triamcinolone—ankylosing spondylitis	0.000544	0.000976	CcSEcCtD
Ziprasidone—Insomnia—Prednisolone—ankylosing spondylitis	0.000544	0.000975	CcSEcCtD
Ziprasidone—Alopecia—Prednisone—ankylosing spondylitis	0.000544	0.000975	CcSEcCtD
Ziprasidone—Shock—Methylprednisolone—ankylosing spondylitis	0.000543	0.000974	CcSEcCtD
Ziprasidone—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000541	0.00097	CcSEcCtD
Ziprasidone—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000541	0.000969	CcSEcCtD
Ziprasidone—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000541	0.000969	CcSEcCtD
Ziprasidone—Epistaxis—Methotrexate—ankylosing spondylitis	0.00054	0.000969	CcSEcCtD
Ziprasidone—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00054	0.000968	CcSEcCtD
Ziprasidone—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00054	0.000968	CcSEcCtD
Ziprasidone—Mental disorder—Prednisone—ankylosing spondylitis	0.000539	0.000966	CcSEcCtD
Ziprasidone—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000539	0.000966	CcSEcCtD
Ziprasidone—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000536	0.000961	CcSEcCtD
Ziprasidone—Malnutrition—Prednisone—ankylosing spondylitis	0.000536	0.00096	CcSEcCtD
Ziprasidone—Erythema—Prednisone—ankylosing spondylitis	0.000536	0.00096	CcSEcCtD
Ziprasidone—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000535	0.000959	CcSEcCtD
Ziprasidone—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000534	0.000957	CcSEcCtD
Ziprasidone—Hypertension—Dexamethasone—ankylosing spondylitis	0.000531	0.000952	CcSEcCtD
Ziprasidone—Hypertension—Betamethasone—ankylosing spondylitis	0.000531	0.000952	CcSEcCtD
Ziprasidone—Myalgia—Dexamethasone—ankylosing spondylitis	0.000524	0.000939	CcSEcCtD
Ziprasidone—Myalgia—Betamethasone—ankylosing spondylitis	0.000524	0.000939	CcSEcCtD
Ziprasidone—Anxiety—Dexamethasone—ankylosing spondylitis	0.000522	0.000935	CcSEcCtD
Ziprasidone—Anxiety—Betamethasone—ankylosing spondylitis	0.000522	0.000935	CcSEcCtD
Ziprasidone—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000517	0.000927	CcSEcCtD
Ziprasidone—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000516	0.000925	CcSEcCtD
Ziprasidone—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000514	0.000922	CcSEcCtD
Ziprasidone—Hepatitis—Methotrexate—ankylosing spondylitis	0.000514	0.000922	CcSEcCtD
Ziprasidone—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00051	0.000915	CcSEcCtD
Ziprasidone—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000508	0.00091	CcSEcCtD
Ziprasidone—Vision blurred—Prednisone—ankylosing spondylitis	0.000505	0.000905	CcSEcCtD
Ziprasidone—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000504	0.000904	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000504	0.000904	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000503	0.000902	CcSEcCtD
Ziprasidone—Insomnia—Triamcinolone—ankylosing spondylitis	0.0005	0.000897	CcSEcCtD
Ziprasidone—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000499	0.000895	CcSEcCtD
Ziprasidone—Infection—Dexamethasone—ankylosing spondylitis	0.000499	0.000894	CcSEcCtD
Ziprasidone—Infection—Betamethasone—ankylosing spondylitis	0.000499	0.000894	CcSEcCtD
Ziprasidone—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000497	0.000891	CcSEcCtD
Ziprasidone—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000496	0.000889	CcSEcCtD
Ziprasidone—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000496	0.000889	CcSEcCtD
Ziprasidone—Visual impairment—Methotrexate—ankylosing spondylitis	0.000496	0.000888	CcSEcCtD
Ziprasidone—Anaemia—Prednisone—ankylosing spondylitis	0.000495	0.000887	CcSEcCtD
Ziprasidone—Shock—Betamethasone—ankylosing spondylitis	0.000494	0.000885	CcSEcCtD
Ziprasidone—Shock—Dexamethasone—ankylosing spondylitis	0.000494	0.000885	CcSEcCtD
Ziprasidone—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000493	0.000884	CcSEcCtD
Ziprasidone—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000492	0.000882	CcSEcCtD
Ziprasidone—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000492	0.000882	CcSEcCtD
Ziprasidone—Agitation—Prednisone—ankylosing spondylitis	0.000492	0.000882	CcSEcCtD
Ziprasidone—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000492	0.000881	CcSEcCtD
Ziprasidone—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000492	0.000881	CcSEcCtD
Ziprasidone—Tachycardia—Betamethasone—ankylosing spondylitis	0.00049	0.000878	CcSEcCtD
Ziprasidone—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00049	0.000878	CcSEcCtD
Ziprasidone—Angioedema—Prednisone—ankylosing spondylitis	0.00049	0.000877	CcSEcCtD
Ziprasidone—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000487	0.000873	CcSEcCtD
Ziprasidone—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000486	0.000871	CcSEcCtD
Ziprasidone—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000485	0.00087	CcSEcCtD
Ziprasidone—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000485	0.00087	CcSEcCtD
Ziprasidone—Vertigo—Prednisone—ankylosing spondylitis	0.000481	0.000863	CcSEcCtD
Ziprasidone—Eye disorder—Methotrexate—ankylosing spondylitis	0.000481	0.000861	CcSEcCtD
Ziprasidone—Syncope—Prednisone—ankylosing spondylitis	0.00048	0.000861	CcSEcCtD
Ziprasidone—Tinnitus—Methotrexate—ankylosing spondylitis	0.00048	0.000859	CcSEcCtD
Ziprasidone—Anorexia—Betamethasone—ankylosing spondylitis	0.000479	0.000858	CcSEcCtD
Ziprasidone—Anorexia—Dexamethasone—ankylosing spondylitis	0.000479	0.000858	CcSEcCtD
Ziprasidone—Urticaria—Prednisolone—ankylosing spondylitis	0.000478	0.000857	CcSEcCtD
Ziprasidone—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000477	0.000856	CcSEcCtD
Ziprasidone—Fatigue—Triamcinolone—ankylosing spondylitis	0.000477	0.000855	CcSEcCtD
Ziprasidone—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000476	0.000853	CcSEcCtD
Ziprasidone—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000471	0.000844	CcSEcCtD
Ziprasidone—Hypotension—Dexamethasone—ankylosing spondylitis	0.000469	0.000841	CcSEcCtD
Ziprasidone—Hypotension—Betamethasone—ankylosing spondylitis	0.000469	0.000841	CcSEcCtD
Ziprasidone—Angiopathy—Methotrexate—ankylosing spondylitis	0.000467	0.000836	CcSEcCtD
Ziprasidone—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000465	0.000833	CcSEcCtD
Ziprasidone—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000464	0.000831	CcSEcCtD
Ziprasidone—Hypertension—Prednisone—ankylosing spondylitis	0.000463	0.000829	CcSEcCtD
Ziprasidone—Chills—Methotrexate—ankylosing spondylitis	0.000462	0.000827	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000457	0.00082	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000457	0.00082	CcSEcCtD
Ziprasidone—Arthralgia—Prednisone—ankylosing spondylitis	0.000456	0.000817	CcSEcCtD
Ziprasidone—Myalgia—Prednisone—ankylosing spondylitis	0.000456	0.000817	CcSEcCtD
Ziprasidone—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000456	0.000817	CcSEcCtD
Ziprasidone—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000455	0.000815	CcSEcCtD
Ziprasidone—Anxiety—Prednisone—ankylosing spondylitis	0.000455	0.000815	CcSEcCtD
Ziprasidone—Alopecia—Methotrexate—ankylosing spondylitis	0.000455	0.000815	CcSEcCtD
Ziprasidone—Insomnia—Betamethasone—ankylosing spondylitis	0.000454	0.000814	CcSEcCtD
Ziprasidone—Insomnia—Dexamethasone—ankylosing spondylitis	0.000454	0.000814	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000453	0.000812	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000451	0.000809	CcSEcCtD
Ziprasidone—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000451	0.000808	CcSEcCtD
Ziprasidone—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000451	0.000808	CcSEcCtD
Ziprasidone—Mental disorder—Methotrexate—ankylosing spondylitis	0.000451	0.000808	CcSEcCtD
Ziprasidone—Erythema—Methotrexate—ankylosing spondylitis	0.000448	0.000802	CcSEcCtD
Ziprasidone—Malnutrition—Methotrexate—ankylosing spondylitis	0.000448	0.000802	CcSEcCtD
Ziprasidone—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000443	0.000795	CcSEcCtD
Ziprasidone—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000442	0.000792	CcSEcCtD
Ziprasidone—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000442	0.000792	CcSEcCtD
Ziprasidone—Urticaria—Triamcinolone—ankylosing spondylitis	0.00044	0.000788	CcSEcCtD
Ziprasidone—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000439	0.000786	CcSEcCtD
Ziprasidone—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000437	0.000784	CcSEcCtD
Ziprasidone—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000436	0.000782	CcSEcCtD
Ziprasidone—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000436	0.000782	CcSEcCtD
Ziprasidone—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000436	0.000782	CcSEcCtD
Ziprasidone—Infection—Prednisone—ankylosing spondylitis	0.000434	0.000779	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000433	0.000777	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000433	0.000777	CcSEcCtD
Ziprasidone—Back pain—Methotrexate—ankylosing spondylitis	0.000433	0.000776	CcSEcCtD
Ziprasidone—Fatigue—Betamethasone—ankylosing spondylitis	0.000433	0.000776	CcSEcCtD
Ziprasidone—Fatigue—Dexamethasone—ankylosing spondylitis	0.000433	0.000776	CcSEcCtD
Ziprasidone—Shock—Prednisone—ankylosing spondylitis	0.00043	0.000771	CcSEcCtD
Ziprasidone—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000429	0.000769	CcSEcCtD
Ziprasidone—Tachycardia—Prednisone—ankylosing spondylitis	0.000427	0.000765	CcSEcCtD
Ziprasidone—Skin disorder—Prednisone—ankylosing spondylitis	0.000425	0.000761	CcSEcCtD
Ziprasidone—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000423	0.000758	CcSEcCtD
Ziprasidone—Vision blurred—Methotrexate—ankylosing spondylitis	0.000422	0.000756	CcSEcCtD
Ziprasidone—Anorexia—Prednisone—ankylosing spondylitis	0.000417	0.000747	CcSEcCtD
Ziprasidone—Anaemia—Methotrexate—ankylosing spondylitis	0.000414	0.000742	CcSEcCtD
Ziprasidone—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000414	0.000742	CcSEcCtD
Ziprasidone—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000414	0.000742	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000411	0.000736	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000411	0.000736	CcSEcCtD
Ziprasidone—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000408	0.000731	CcSEcCtD
Ziprasidone—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000407	0.000729	CcSEcCtD
Ziprasidone—Vertigo—Methotrexate—ankylosing spondylitis	0.000402	0.000721	CcSEcCtD
Ziprasidone—Leukopenia—Methotrexate—ankylosing spondylitis	0.000401	0.000718	CcSEcCtD
Ziprasidone—Urticaria—Betamethasone—ankylosing spondylitis	0.000399	0.000715	CcSEcCtD
Ziprasidone—Urticaria—Dexamethasone—ankylosing spondylitis	0.000399	0.000715	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000398	0.000714	CcSEcCtD
Ziprasidone—Dizziness—Prednisolone—ankylosing spondylitis	0.000398	0.000713	CcSEcCtD
Ziprasidone—Asthenia—Triamcinolone—ankylosing spondylitis	0.000397	0.000712	CcSEcCtD
Ziprasidone—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000397	0.000711	CcSEcCtD
Ziprasidone—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000397	0.000711	CcSEcCtD
Ziprasidone—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000397	0.000711	CcSEcCtD
Ziprasidone—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000397	0.000711	CcSEcCtD
Ziprasidone—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000396	0.00071	CcSEcCtD
Ziprasidone—Insomnia—Prednisone—ankylosing spondylitis	0.000395	0.000709	CcSEcCtD
Ziprasidone—Paraesthesia—Prednisone—ankylosing spondylitis	0.000393	0.000704	CcSEcCtD
Ziprasidone—Cough—Methotrexate—ankylosing spondylitis	0.000391	0.0007	CcSEcCtD
Ziprasidone—Dyspepsia—Prednisone—ankylosing spondylitis	0.000385	0.00069	CcSEcCtD
Ziprasidone—Chest pain—Methotrexate—ankylosing spondylitis	0.000381	0.000683	CcSEcCtD
Ziprasidone—Arthralgia—Methotrexate—ankylosing spondylitis	0.000381	0.000683	CcSEcCtD
Ziprasidone—Myalgia—Methotrexate—ankylosing spondylitis	0.000381	0.000683	CcSEcCtD
Ziprasidone—Decreased appetite—Prednisone—ankylosing spondylitis	0.00038	0.000681	CcSEcCtD
Ziprasidone—Rash—Prednisolone—ankylosing spondylitis	0.000379	0.00068	CcSEcCtD
Ziprasidone—Dermatitis—Prednisolone—ankylosing spondylitis	0.000379	0.000679	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000379	0.000678	CcSEcCtD
Ziprasidone—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000378	0.000677	CcSEcCtD
Ziprasidone—Fatigue—Prednisone—ankylosing spondylitis	0.000377	0.000676	CcSEcCtD
Ziprasidone—Headache—Prednisolone—ankylosing spondylitis	0.000377	0.000676	CcSEcCtD
Ziprasidone—Constipation—Prednisone—ankylosing spondylitis	0.000374	0.00067	CcSEcCtD
Ziprasidone—Confusional state—Methotrexate—ankylosing spondylitis	0.000368	0.00066	CcSEcCtD
Ziprasidone—Dizziness—Triamcinolone—ankylosing spondylitis	0.000366	0.000656	CcSEcCtD
Ziprasidone—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000365	0.000654	CcSEcCtD
Ziprasidone—Infection—Methotrexate—ankylosing spondylitis	0.000363	0.000651	CcSEcCtD
Ziprasidone—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00036	0.000646	CcSEcCtD
Ziprasidone—Asthenia—Dexamethasone—ankylosing spondylitis	0.00036	0.000646	CcSEcCtD
Ziprasidone—Asthenia—Betamethasone—ankylosing spondylitis	0.00036	0.000646	CcSEcCtD
Ziprasidone—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000358	0.000642	CcSEcCtD
Ziprasidone—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000358	0.000641	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000358	0.000641	CcSEcCtD
Ziprasidone—Nausea—Prednisolone—ankylosing spondylitis	0.000357	0.000641	CcSEcCtD
Ziprasidone—Skin disorder—Methotrexate—ankylosing spondylitis	0.000355	0.000636	CcSEcCtD
Ziprasidone—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000353	0.000633	CcSEcCtD
Ziprasidone—Vomiting—Triamcinolone—ankylosing spondylitis	0.000352	0.000631	CcSEcCtD
Ziprasidone—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000351	0.000629	CcSEcCtD
Ziprasidone—Rash—Triamcinolone—ankylosing spondylitis	0.000349	0.000625	CcSEcCtD
Ziprasidone—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000349	0.000625	CcSEcCtD
Ziprasidone—Anorexia—Methotrexate—ankylosing spondylitis	0.000348	0.000624	CcSEcCtD
Ziprasidone—Rash—Methylprednisolone—ankylosing spondylitis	0.000348	0.000624	CcSEcCtD
Ziprasidone—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000348	0.000623	CcSEcCtD
Ziprasidone—Urticaria—Prednisone—ankylosing spondylitis	0.000347	0.000623	CcSEcCtD
Ziprasidone—Headache—Triamcinolone—ankylosing spondylitis	0.000347	0.000621	CcSEcCtD
Ziprasidone—Headache—Methylprednisolone—ankylosing spondylitis	0.000346	0.00062	CcSEcCtD
Ziprasidone—Body temperature increased—Prednisone—ankylosing spondylitis	0.000346	0.00062	CcSEcCtD
Ziprasidone—Abdominal pain—Prednisone—ankylosing spondylitis	0.000346	0.00062	CcSEcCtD
Ziprasidone—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000344	0.000616	CcSEcCtD
Ziprasidone—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000344	0.000616	CcSEcCtD
Ziprasidone—Hypotension—Methotrexate—ankylosing spondylitis	0.000341	0.000612	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000333	0.000597	CcSEcCtD
Ziprasidone—Dizziness—Betamethasone—ankylosing spondylitis	0.000332	0.000595	CcSEcCtD
Ziprasidone—Dizziness—Dexamethasone—ankylosing spondylitis	0.000332	0.000595	CcSEcCtD
Ziprasidone—Insomnia—Methotrexate—ankylosing spondylitis	0.000331	0.000592	CcSEcCtD
Ziprasidone—Nausea—Triamcinolone—ankylosing spondylitis	0.000329	0.000589	CcSEcCtD
Ziprasidone—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000328	0.000588	CcSEcCtD
Ziprasidone—Nausea—Methylprednisolone—ankylosing spondylitis	0.000328	0.000588	CcSEcCtD
Ziprasidone—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000326	0.000584	CcSEcCtD
Ziprasidone—Somnolence—Methotrexate—ankylosing spondylitis	0.000325	0.000582	CcSEcCtD
Ziprasidone—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000322	0.000577	CcSEcCtD
Ziprasidone—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000322	0.000577	CcSEcCtD
Ziprasidone—Vomiting—Betamethasone—ankylosing spondylitis	0.000319	0.000572	CcSEcCtD
Ziprasidone—Vomiting—Dexamethasone—ankylosing spondylitis	0.000319	0.000572	CcSEcCtD
Ziprasidone—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000318	0.000569	CcSEcCtD
Ziprasidone—Rash—Dexamethasone—ankylosing spondylitis	0.000317	0.000567	CcSEcCtD
Ziprasidone—Rash—Betamethasone—ankylosing spondylitis	0.000317	0.000567	CcSEcCtD
Ziprasidone—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000316	0.000567	CcSEcCtD
Ziprasidone—Dermatitis—Betamethasone—ankylosing spondylitis	0.000316	0.000567	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000315	0.000565	CcSEcCtD
Ziprasidone—Fatigue—Methotrexate—ankylosing spondylitis	0.000315	0.000565	CcSEcCtD
Ziprasidone—Headache—Dexamethasone—ankylosing spondylitis	0.000315	0.000564	CcSEcCtD
Ziprasidone—Headache—Betamethasone—ankylosing spondylitis	0.000315	0.000564	CcSEcCtD
Ziprasidone—Asthenia—Prednisone—ankylosing spondylitis	0.000314	0.000562	CcSEcCtD
Ziprasidone—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000301	0.00054	CcSEcCtD
Ziprasidone—Diarrhoea—Prednisone—ankylosing spondylitis	0.000299	0.000536	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000299	0.000536	CcSEcCtD
Ziprasidone—Nausea—Betamethasone—ankylosing spondylitis	0.000298	0.000535	CcSEcCtD
Ziprasidone—Nausea—Dexamethasone—ankylosing spondylitis	0.000298	0.000535	CcSEcCtD
Ziprasidone—Urticaria—Methotrexate—ankylosing spondylitis	0.00029	0.00052	CcSEcCtD
Ziprasidone—Dizziness—Prednisone—ankylosing spondylitis	0.000289	0.000518	CcSEcCtD
Ziprasidone—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000289	0.000518	CcSEcCtD
Ziprasidone—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000289	0.000518	CcSEcCtD
Ziprasidone—Vomiting—Prednisone—ankylosing spondylitis	0.000278	0.000498	CcSEcCtD
Ziprasidone—Rash—Prednisone—ankylosing spondylitis	0.000276	0.000494	CcSEcCtD
Ziprasidone—Dermatitis—Prednisone—ankylosing spondylitis	0.000275	0.000494	CcSEcCtD
Ziprasidone—Headache—Prednisone—ankylosing spondylitis	0.000274	0.000491	CcSEcCtD
Ziprasidone—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000269	0.000483	CcSEcCtD
Ziprasidone—Asthenia—Methotrexate—ankylosing spondylitis	0.000262	0.00047	CcSEcCtD
Ziprasidone—Nausea—Prednisone—ankylosing spondylitis	0.00026	0.000465	CcSEcCtD
Ziprasidone—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00025	0.000448	CcSEcCtD
Ziprasidone—Dizziness—Methotrexate—ankylosing spondylitis	0.000242	0.000433	CcSEcCtD
Ziprasidone—Vomiting—Methotrexate—ankylosing spondylitis	0.000232	0.000416	CcSEcCtD
Ziprasidone—Rash—Methotrexate—ankylosing spondylitis	0.00023	0.000413	CcSEcCtD
Ziprasidone—Dermatitis—Methotrexate—ankylosing spondylitis	0.00023	0.000413	CcSEcCtD
Ziprasidone—Headache—Methotrexate—ankylosing spondylitis	0.000229	0.00041	CcSEcCtD
Ziprasidone—Nausea—Methotrexate—ankylosing spondylitis	0.000217	0.000389	CcSEcCtD
